Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations

The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.

Read the full post on Forbes - Healthcare

Alex Knapp, Forbes Staff